Clinical Trial

DCSZ11 in Combination With Standard Therapy in Advanced or Metastatic Solid Tumors

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
To evaluate the safety and efficacy of DCSZ11 in combination with standard therapy in patients with advanced or metastatic solid tumors.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-06-15; most recent amendment 2026-03-08.
Status change: Not Yet Recruiting → Recruiting 2026-03-08
Trial Details
NCT Number NCT07035249
Lead Sponsor West China Hospital
Conditions DCSZ11, Solid Tumors, HNSCC
Enrollment 9 participants
Start Date 2025-12-16
Primary Completion 2027-06-01 (estimated)
Study Completion 2027-07-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-11